Analysts predict sales of Dato-DXd could hit $5.9 billion in 2030, but the antibody-drug conjugate faced a series of setbacks ...
workflow to same-day avian influenza surveillance, 16S and internal transcribed spacer (ITS) sequencing, followed by the opportunity to engage in a live Q&A session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback